Neutralization of SARS‐CoV‐2 requires antibodies against conformational receptor‐binding domain epitopes

Abstract

These results are fundamental for estimating the protective activity of antibody responses after natural infection or vaccination and for the design of vaccines, which can induce high levels of SARS-CoV-2-neutralizing antibodies conferring sterilizing immunity.